Pegylated Interferon and Ribavirin Treatment of Chronic Hepatitis C Coinfection in a Patient with Human Immunodeficiency Virus Infection

被引：0

作者：

Kaptan, Figen ^{[1
]}

Turker, Nesrin ^{[1
]}

Ormen, Bahar ^{[1
]}

El, Sibel ^{[1
]}

Hekimoglu, Can Huseyin ^{[1
]}

Vardar, Ilknur ^{[1
]}

Ural, Serap ^{[1
]}

Sener, Asli Gamze ^{[2
]}

Coskun, Nejat Ali ^{[1
]}

机构：

[1] Izmir Ataturk Egitim & Arastirma Hastanesi, Infeksiyon Hastaliklari & Klin Mikrobiyol Klin, Izmir, Turkey

[2] Izmir Ataturk Egitim & Arastirma Hastanesi, Tibbi Mikrobiyol Lab, Izmir, Turkey

来源：

KLIMIK JOURNAL | 2011年 / 24卷 / 02期

关键词：

HIV; HCV antibodies; coinfection; pegylated interferon alpha 2a; ribavirin;

D O I：

10.5152/kd.2011.30

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Human immunodeficiency virus (HIV) and hepatitis C virus (HCV)coinfection is seen frequently due to similar routes of transmission. In coinfected patients, progression of chronic hepatitis C (CHC) infection is accelerated. In this study, a 44-year old male patient with HIV/HCV (genotype 1b) coinfection is evaluated. For the treatment of CHC, pegylated interferon alpha 2a 180 mg per week and ribavirin 1000 mg/day were used for 48 weeks and sustained virologic response was achieved. During the course of CHC treatment no adverse effect was seen.

引用

页码：122 / 125

页数：4

共 38 条

[1] Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV co-infected patients [J].

Alberti, A ;

Clumeck, N ;

Collins, S ;

Gerlich, W ;

Lundgren, J ;

Palù, G ;

Reiss, P ;

Thiebaut, R ;

Weiland, O ;

Yazdanpanah, Y ;

Zeuzem, S .

JOURNAL OF HEPATOLOGY, 2005, 42 (05) :615-624

[2] Epidemiology of viral hepatitis and HIV co-infection [J].

Alter, MJ .

JOURNAL OF HEPATOLOGY, 2006, 44 :S6-S9

[3] Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy [J].

Bani-Sadr, F ;

Carrat, F ;

Pol, S ;

Hor, R ;

Rosenthal, E ;

Goujard, C ;

Morand, P ;

Lunel-Fabiani, F ;

Salmon-Ceron, D ;

Piroth, L ;

Pialoux, G ;

Bentata, M ;

Cacoub, P ;

Perronne, C .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (01) :47-52

[4] Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination - Does abacavir play a role? [J].

Bani-Sadr, Firouze ;

Denoeud, Lise ;

Morand, Patrice ;

Lunel-Fabiani, Francoise ;

Pol, Stanislas ;

Cacoub, Patrice ;

Perronne, Christian ;

Carrat, Fabrice .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (01) :123-125

[5] Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients [J].

Benhamou, Y ;

Bochet, M ;

Di Martino, V ;

Charlotte, F ;

Azria, F ;

Coutellier, A ;

Vidaud, M ;

Bricaire, F ;

Opolon, P ;

Katlama, C ;

Poynard, T .

HEPATOLOGY, 1999, 30 (04) :1054-1058

[6] Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection [J].

Bica, I ;

McGovern, B ;

Dhar, R ;

Stone, D ;

McGowan, K ;

Scheib, R ;

Snydman, DR .

CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) :492-497

[7]

Butt AA, 2009, HIV CLIN TRIALS, V10, P25, DOI [10.1310/hct1001-025, 10.1310/hct1001-25]

[8] Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons [J].

Chung, RT ;

Andersen, J ;

Volberding, P ;

Robbins, GK ;

Liu, T ;

Sherman, KE ;

Peters, MG ;

Koziel, MJ ;

Bhan, AK ;

Alston, B ;

Colquhoun, D ;

Nevin, T ;

Harb, G ;

van der Horst, C .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05) :451-459

[9]

de Ledinghen V, 2006, JAIDS-J ACQ IMM DEF, V41, P175

[10]

Erbay A, 2003, TURK HIV AIDS DERG, V6, P43

← 1 2 3 4 →